SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

Alexion Shareholders Approve Acquisition by AstraZeneca

05/11/2021 06:05

10:01 AM EDT, 05/11/2021 (MT Newswires) -- Alexion Pharmaceuticals (ALXN) said Tuesday its shareholders have voted to approve the company's acquisition by AstraZeneca (AZN).

In December 2020, the Boston-based biopharmaceutical company agreed to be acquired by the British drugmaker in a cash-and-stock deal worth $39 billion.

The deal is expected to close in Q3, subject to regulatory clearances.

Shares were marginally lower in morning session.

Price: 170.86, Change: -0.95, Percent Change: -0.55